.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Express Scripts
Queensland Health
McKinsey
Fuji
Merck
Novartis
Medtronic
Chubb
Daiichi Sankyo

Generated: September 26, 2017

DrugPatentWatch Database Preview

ERYTHROMYCIN Drug Profile

« Back to Dashboard

Which patents cover Erythromycin, and when can generic versions of Erythromycin launch?

Erythromycin is a drug marketed by Paddock Llc, Perrigo Co, Akorn, Pharmafair, Fougera Pharms, Arbor Pharms Llc, Wockhardt, Alpharma Us Pharms, Renaissance Pharma, Mylan Pharms Inc, Lilly, Perrigo New York, Bausch And Lomb, Pharmaderm, Perrigo Co Tennessee, Teligent Pharma Inc, Elkins Sinn, Barr, Tolmar, Lyne, Ivax Sub Teva Pharms, Life Labs, G And W Labs Inc, Watson Labs, Parke Davis, Mylan, Ani Pharms Inc, Naska, Dista, Abraxis Pharm, Teva Parenteral, Baxter Hlthcare, Purepac Pharm, and Lederle. and is included in sixty NDAs.

The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are ninety-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.

Summary for Tradename: ERYTHROMYCIN

Patents:0
Applicants:34
NDAs:60
Suppliers / Packagers: see list34
Bulk Api Vendors: see list42
Clinical Trials: see list94
Patent Applications: see list802
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYTHROMYCIN at DailyMed

Pharmacology for Tradename: ERYTHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
ERYTHROMYCIN STEARATE
erythromycin stearate
TABLET;ORAL062089-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
ERYTHROMYCIN ESTOLATE
erythromycin estolate
SUSPENSION;ORAL062169-001Oct 17, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
ERYTHROMYCIN
erythromycin
CAPSULE, DELAYED REL PELLETS;ORAL063098-001May 4, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
TABLET;ORAL062847-001Sep 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION063253-002Jul 30, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062200-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
GRANULE;ORAL062055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062177-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION063253-001Jul 30, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
ERYTHROMYCIN
erythromycin
OINTMENT;OPHTHALMIC062481-001Apr 5, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Chubb
Healthtrust
Teva
Cipla
Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot